To determine whether known targets of LIN28A/LIN28B would be able to rescue cancer initiation in Lin28a/Lin28b-deficient mice, we tested Igf2bp1, Igf2bp2, and Igf2bp3. This evidence concerns the gene IGF2BP2 and cancer.